An insightful look into neuromodulation, a cutting-edge, non-invasive technology helping children and adolescents with a ...

Neurostimulation and neuromodulation are next-generation treatments that harness the brain's regenerative ability to restore ...

New discovery shows that a unique nanomaterial called graphitic carbon nitride (g-C N ) has been shown to stimulate your ...

As depression cases rise, can neuromodulation offer a faster, side-effect-free alternative to medication? Neurotech startup ...

Medtronic (NYSE: MDT) today reported the first patient treated with its Altaviva neuromodulation device for urge urinary ...

Medtronic (MDT) just grabbed headlines with FDA approval for its Altaviva device, a minimally invasive implantable treatment ...

The Neuromodulation Market is witnessing significant momentum due to the growing prevalence of chronic disorders, ...

Medtronic has received FDA approval for a new implant aimed at improving bladder control, with a small device placed near the ...

Funds will enable company to launch a clinical trial in patients with drug-resistant depression and finalize development of ...

The global Neuromodulation Market , valued at US$6.26 billion in 2024, stood at US$6.81 billion in 2025 and is projected to ...

The Food and Drug Administration has cleared Medtronic’s Altaviva device for the treatment of urge urinary incontinence.